Results from the first clinical trial using neural stem cells to treat people with MS
It is important for people with MS to have the best available information on stem cell therapy to make decisions related to this complex issue.
Thousands of scientists are undertaking research into all aspects of MS, furthering our understanding of the disease and how to prevent, treat and manage it.
Global trial of mesenchymal stem cell therapy showed no reduction in inflammation for people with active MS
Research and clinical trials are taking place around the world, trying to find and improve treatments for MS
Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other MS therapies have been presented at a Lisbon conference.
International study looks at long-term progression in people with MS following stem cell therapy
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) is being investigated as a treatment for MS
Rebooting immune system provides long term relief for aggressive relapsing MS in Canadian study
The results of a multi-centre, phase II, randomized trial
The Mesenchymal Stem Cell Therapy for Canadian MS Patients Study is part of a larger international research effort
Study shows improvement in neurological disability and other clinical outcomes